New Approaches to Manage Infections in Transplant Recipients: Report From the 2023 GTI (Infection and Transplantation Group) Annual Meeting.
作者信息
Serris Alexandra, Coussement Julien, Pilmis Benoît, De Lastours Victoire, Dinh Aurélien, Parquin François, Epailly Eric, Ader Florence, Lortholary Olivier, Morelon Emmanuel, Kamar Nassim, Forcade Edouard, Lebeaux David, Dumortier Jérôme, Conti Filomena, Lefort Agnes, Scemla Anne, Kaminski Hannah
机构信息
Department of Infectious Diseases, Necker-Enfants Malades University Hospital, Paris, France.
Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
出版信息
Transpl Int. 2023 Nov 9;36:11859. doi: 10.3389/ti.2023.11859. eCollection 2023.
Abstract
摘要
相似文献
1
New Approaches to Manage Infections in Transplant Recipients: Report From the 2023 GTI (Infection and Transplantation Group) Annual Meeting.移植受者感染管理的新方法：来自2023年GTI（感染与移植小组）年会的报告。
Transpl Int. 2023 Nov 9;36:11859. doi: 10.3389/ti.2023.11859. eCollection 2023.
2
Urinary tract infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.实体器官移植受者的尿路感染：美国移植感染病学会实践社区指南。
Clin Transplant. 2019 Sep;33(9):e13507. doi: 10.1111/ctr.13507. Epub 2019 Mar 28.
3
Recurrence of urinary tract infections and development of urinary-specific antibiogram for kidney transplant recipients.移植肾受者尿路感染的复发和尿特定抗生素耐药谱的发展。
J Glob Antimicrob Resist. 2018 Mar;12:119-123. doi: 10.1016/j.jgar.2017.08.009. Epub 2017 Aug 30.
4
Opportunities for Antimicrobial Stewardship Interventions Among Solid Organ Transplant Recipients.实体器官移植受者中抗菌药物管理干预的机会。
Infect Dis Clin North Am. 2023 Sep;37(3):539-560. doi: 10.1016/j.idc.2023.04.005. Epub 2023 Jun 4.
5
Antimicrobial stewardship in pediatric solid organ transplantation: Is it possible?儿科实体器官移植中的抗菌药物管理：这可行吗？
Transpl Infect Dis. 2022 Oct;24(5):e13928. doi: 10.1111/tid.13928.
6
Antimicrobial stewardship in solid organ transplant recipients: Current challenges and proposed metrics.实体器官移植受者中的抗菌药物管理：当前的挑战和建议的衡量标准。
Transpl Infect Dis. 2022 Oct;24(5):e13883. doi: 10.1111/tid.13883.
7
Brazilian perspective: antimicrobial stewardship in solid organ transplant.巴西视角：实体器官移植中的抗菌药物管理。
Transpl Infect Dis. 2022 Oct;24(5):e13874. doi: 10.1111/tid.13874.
8
Multidrug-resistant Gram-negative bacterial infections in solid organ transplant recipients-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.实体器官移植受者中耐多药革兰氏阴性菌感染-美国移植感染病学会实践社区指南。
Clin Transplant. 2019 Sep;33(9):e13594. doi: 10.1111/ctr.13594. Epub 2019 Jul 22.
9
White paper on antimicrobial stewardship in solid organ transplant recipients.实体器官移植受者抗菌药物管理白皮书。
Am J Transplant. 2022 Jan;22(1):96-112. doi: 10.1111/ajt.16743. Epub 2021 Aug 2.
10
The time is now: antimicrobial stewardship in solid organ transplantation.当下时机已至：实体器官移植中的抗菌药物管理
Curr Opin Organ Transplant. 2021 Aug 1;26(4):405-411. doi: 10.1097/MOT.0000000000000886.
引用本文的文献
1
Effect of increasing age and ureteral stent implantation on urinary tract infections after kidney transplantation - update of recent literature.年龄增长和输尿管支架植入对肾移植后尿路感染的影响 - 最新文献综述。
Curr Opin Urol. 2024 May 1;34(3):146-153. doi: 10.1097/MOU.0000000000001163. Epub 2024 Mar 7.
本文引用的文献
1
Absence of Clinically Meaningful Drug-Drug Interactions with Rezafungin: Outcome of Investigations.无临床意义的药物相互作用 Rezafungin：研究结果。
Microbiol Spectr. 2023 Jun 15;11(3):e0133923. doi: 10.1128/spectrum.01339-23. Epub 2023 May 8.
2
Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae.头孢他啶-阿维巴坦治疗产碳青霉烯酶肺炎克雷伯菌血流感染的实体器官移植受者的疗效。
Am J Transplant. 2023 Jul;23(7):1022-1034. doi: 10.1016/j.ajt.2023.03.011. Epub 2023 Apr 5.
3
The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline.细菌疫苗在对抗抗菌药物耐药性中的作用：临床前和临床研发管道分析。
Lancet Microbe. 2023 Feb;4(2):e113-e125. doi: 10.1016/S2666-5247(22)00303-2. Epub 2022 Dec 14.
4
Duration of antibiotics in kidney transplant recipients with pyelonephritis: Current practice, research gaps, and future research.肾移植受者肾盂肾炎抗生素治疗疗程：当前实践、研究差距及未来研究
Transpl Infect Dis. 2023 Feb;25(1):e13997. doi: 10.1111/tid.13997. Epub 2022 Dec 10.
5
Duration of antibiotic treatment for acute graft pyelonephritis: What's the standard of care?急性移植肾盂肾炎的抗生素治疗疗程：护理标准是什么？
Transpl Infect Dis. 2023 Feb;25(1):e13996. doi: 10.1111/tid.13996. Epub 2022 Dec 10.
6
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial.瑞扎芬净与卡泊芬净治疗念珠菌血症和侵袭性念珠菌病的疗效比较（ReSTORE）：一项多中心、双盲、双模拟、随机3期试验。
Lancet. 2023 Jan 7;401(10370):49-59. doi: 10.1016/S0140-6736(22)02324-8. Epub 2022 Nov 25.
7
Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy.采用基于头孢地尔的方案成功治疗1例血液系统恶性肿瘤患者的多重耐药嗜麦芽窄食单胞菌相关性肺炎。
Ann Hematol. 2022 Dec;101(12):2805-2806. doi: 10.1007/s00277-022-05006-3. Epub 2022 Oct 27.
8
Treatment of asymptomatic bacteriuria in the first 2 months after kidney transplant: A controlled clinical trial.肾移植后前2个月无症状菌尿的治疗：一项对照临床试验。
Transpl Infect Dis. 2022 Dec;24(6):e13934. doi: 10.1111/tid.13934. Epub 2022 Aug 28.
9
Comparison of Sequential Dalbavancin With Standard-of-Care Treatment for Bloodstream Infections.序贯达巴万星与标准治疗方案治疗血流感染的比较。
Open Forum Infect Dis. 2022 Jul 14;9(7):ofac335. doi: 10.1093/ofid/ofac335. eCollection 2022 Jul.
10
Successful expanded access use of rezafungin, a novel echinocandin, to eradicate refractory invasive candidiasis in a liver transplant recipient.新型棘白菌素瑞扎芬净成功通过扩大可及性使用，根除肝移植受者难治性侵袭性念珠菌病。
J Antimicrob Chemother. 2022 Aug 25;77(9):2571-2573. doi: 10.1093/jac/dkac206.
Zotero 插件